These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 30842313)

  • 1. Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.
    Nyberg S; Abbott NJ; Shi X; Steyger PS; Dabdoub A
    Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inner ear drug delivery for auditory applications.
    Swan EE; Mescher MJ; Sewell WF; Tao SL; Borenstein JT
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1583-99. PubMed ID: 18848590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications.
    Salt AN; Plontke SK
    Hear Res; 2018 Oct; 368():28-40. PubMed ID: 29551306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical basis of drug delivery to the inner ear.
    Glueckert R; Johnson Chacko L; Rask-Andersen H; Liu W; Handschuh S; Schrott-Fischer A
    Hear Res; 2018 Oct; 368():10-27. PubMed ID: 30442227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local drug delivery to the inner ear: Principles, practice, and future challenges.
    Plontke SK; Salt AN
    Hear Res; 2018 Oct; 368():1-2. PubMed ID: 30006112
    [No Abstract]   [Full Text] [Related]  

  • 6. Diseases and targets for local drug delivery to the inner ear.
    Lustig LR
    Hear Res; 2018 Oct; 368():3-9. PubMed ID: 29778289
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss.
    Rivera T; Sanz L; Camarero G; Varela-Nieto I
    Curr Drug Deliv; 2012 May; 9(3):231-42. PubMed ID: 22283653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in local drug delivery to the inner ear.
    El Kechai N; Agnely F; Mamelle E; Nguyen Y; Ferrary E; Bochot A
    Int J Pharm; 2015 Oct; 494(1):83-101. PubMed ID: 26260230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB).
    Shi X; Wang Z; Ren W; Chen L; Xu C; Li M; Fan S; Xu Y; Chen M; Zheng F; Zhang W; Zhou X; Zhang Y; Qiu S; Wu L; Zhou P; Lv X; Cui T; Qiao Y; Zhao H; Guo W; Chen W; Li S; Zhong W; Lin J; Yang S
    Signal Transduct Target Ther; 2022 Jun; 7(1):175. PubMed ID: 35680846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outlook and future of inner ear therapy.
    Devare J; Gubbels S; Raphael Y
    Hear Res; 2018 Oct; 368():127-135. PubMed ID: 29804723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner ear drug delivery: Recent advances, challenges, and perspective.
    Hao J; Li SK
    Eur J Pharm Sci; 2019 Jan; 126():82-92. PubMed ID: 29792920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of nanoparticle drug-delivery systems for the inner ear.
    An X; Zha D
    Nanomedicine (Lond); 2020 Aug; 15(20):1981-1993. PubMed ID: 32605499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials for inner ear drugs: Design and execution challenges.
    Jung DH; Rauch SD
    Hear Res; 2018 Oct; 368():123-126. PubMed ID: 29602591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in the studies of novel nanomaterials for inner ear drug delivery.
    Zhang L; Bai X; Wang R; Xu L; Ma J; Xu Y; Lu Z
    Nanomedicine (Lond); 2022 Aug; 17(20):1463-1475. PubMed ID: 36189895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled drug release to the inner ear: Concepts, materials, mechanisms, and performance.
    Mäder K; Lehner E; Liebau A; Plontke SK
    Hear Res; 2018 Oct; 368():49-66. PubMed ID: 29576310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication pathways to and from the inner ear and their contributions to drug delivery.
    Salt AN; Hirose K
    Hear Res; 2018 May; 362():25-37. PubMed ID: 29277248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Breakdown of Blood-Labyrinth Barrier Makes it Easier for Drugs to Enter the Inner Ear.
    Ke Y; Ma X; Jing Y; Diao T; Yu L
    Laryngoscope; 2024 May; 134(5):2377-2386. PubMed ID: 37987231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Issues in Hearing Rehabilitation.
    Bird PA; Bergin MJ
    Adv Otorhinolaryngol; 2018; 81():114-122. PubMed ID: 29794456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015).
    Nguyen K; Kempfle JS; Jung DH; McKenna CE
    Expert Opin Ther Pat; 2017 Feb; 27(2):191-202. PubMed ID: 27855527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Delivery of Therapeutics to the Cochlea Using Nanoparticles and Other Biomaterials.
    Dash S; Zuo J; Steyger PS
    Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.